Duloxetine 60 to 120 mg Versus Placebo in the Treatment of Patients With Osteoarthritis Knee Pain.
Phase of Trial: Phase III
Latest Information Update: 01 Dec 2009
At a glance
- Drugs Duloxetine (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 31 Aug 2018 Biomarkers information updated
- 01 Dec 2009 Results published in Pain.
- 30 Jan 2009 Primary endpoint 'Pain relief' has been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History